175610-68-1 Usage
Description
1-bromo-2-fluoro-3-methyl-5-nitrobenzene is an organic compound characterized by its unique structure, which features a bromo, fluoro, and nitro group attached to different positions of a benzene ring, along with a methyl group. 1-bromo-2-fluoro-3-methyl-5-nitrobenzene is known for its potential applications in the synthesis of various pharmaceutical compounds.
Uses
1. Used in Pharmaceutical Industry:
1-bromo-2-fluoro-3-methyl-5-nitrobenzene is used as a key intermediate in the synthesis of Thienopyridinyl and Thienopyrimidyl compounds. These compounds serve as modulators of ubiquitin-specific-processing protease 7 (USP7), which play a crucial role in the treatment of cancer. By targeting USP7, these compounds can potentially inhibit the growth and progression of cancer cells, making them valuable in the development of novel cancer therapeutics.
2. Used in the Synthesis of Other Compounds:
1-bromo-2-fluoro-3-methyl-5-nitrobenzene, due to its distinct functional groups, can also be utilized in the preparation of other organic compounds with potential applications in various industries, such as materials science, agrochemicals, and dyes. Its versatility in chemical reactions allows for the creation of a wide range of products with diverse properties and uses.
Check Digit Verification of cas no
The CAS Registry Mumber 175610-68-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,6,1 and 0 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 175610-68:
(8*1)+(7*7)+(6*5)+(5*6)+(4*1)+(3*0)+(2*6)+(1*8)=141
141 % 10 = 1
So 175610-68-1 is a valid CAS Registry Number.
175610-68-1Relevant articles and documents
The effect of fluorine substitution on the antimalarial activity of tebuquine
O'Neill, Paul M.,Hawley, Shaun R.,Storr, Richard C.,Ward, Stephen A.,Park, B. Kevin
, p. 391 - 392 (1996)
A novel synthetic route has been developed for the synthesis of fluorotebuquine which was active against the chloroquine resistant K1 strain of Plasmodium falciparum, but less potent than both chloroquine and tebuquine against the 3D7 strain.
